Skip to main content
SpringerLink
Log in

Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The PvuII and XbaI polymorphisms of the estrogen receptor α (ER1) gene have been variably associated with type 2 diabetes (T2D) in several populations. However, this association has not been studied in Iranian subjects and we hypothesized that the ER1 variants might be associated with T2D and related metabolic traits in this population. The PvuII and XbaI genotypes were determined by PCR-RFLP in 377 normoglycemic controls and 155 T2D patients. Bonferroni correction was applied for the correction of multiple testing. No significant association was found between the allele and genotype frequencies of PvuII and XbaI variants with T2D in females. In a dominant model (PP vs. Pp + pp), the frequency of the Pp + pp genotype was higher in normoglycemic subjects compared to T2D patients [85.5% vs. 66.7%, OR 0.22 (0.08–0.55), P = 0.001]. Four possible haplotypes were observed in the population, whereas haplotype TA had a higher frequency in male T2D subjects than the controls. Furthermore, non-diabetic male subjects carrying the genotype of PP had a higher fasting glucose levels than the individuals with the genotype of Pp + pp (P = 0.013). Multivariate logistic regression analysis showed that PvuII polymorphism was the independent determinants of T2D in males [OR 4.37 (1.61–11.86), P = 0.004]. No association was found between the XbaI polymorphism and diabetes in male group. Our results suggest that the ER1 polymorphisms might associate with T2D and fasting glucose among Iranian male subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025. Diabetes Care 21:1414–1431

    Article  PubMed  CAS  Google Scholar 

  2. Meshkani R, Adeli K (2009) Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 42:1331–1346

    Article  PubMed  CAS  Google Scholar 

  3. Meshkani R, Adeli K (2009) Mechanisms linking the metabolic syndrome and cardiovascular disease: role of hepatic insulin resistance. J Teh Univ Heart Ctr 2:77–84

    Google Scholar 

  4. Meshkani R, Taghikhani M, Larijani B, Khatami Sh, Khoshbin E, Adeli K (2006) The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin ChimActa 371:169–175

    Article  CAS  Google Scholar 

  5. Hamman R (1992) Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Res Rev 8:287–338

    Article  CAS  Google Scholar 

  6. Meshkani R, Taghikhani M, Mosapour A, Larijani B, Khatami Sh, Khoshbin E (2007) 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population. Arch Med Res 38:556–562

    Article  PubMed  CAS  Google Scholar 

  7. Al-Harbi EM, Farid EM, Gumaa KA, Masuadi EM, Singh J (2011) Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population. Mol Cell Biochem 350:119–125

    Article  PubMed  CAS  Google Scholar 

  8. Li T, Wu X, Zhu X, Li J, Pan L, Li P, Xin Z, Liu Y (2011) Association analyses between the genetic polymorphisms of HNF4A and FOXO1 genes and Chinese Han patients with type 2 diabetes. Mol Cell Biochem (in press)

  9. Menasce LP, White GR, Harrison CJ, Boyle JM (1993) Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17:263–265

    Article  PubMed  CAS  Google Scholar 

  10. Casazza K, Page GP, Fernandez JR (2010) The association between the rs2234693 and rs9340799 estrogen receptor α gene polymorphisms and risk factors for cardiovascular disease: a review. Biol Res Nurs 12:84–97

    Article  PubMed  CAS  Google Scholar 

  11. Dechering K, Boersma C, Mosselman S (2000) Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem 7:561–576

    PubMed  CAS  Google Scholar 

  12. Muramatsu M, Inoue S (2000) Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun; 270:1–10

    Article  PubMed  CAS  Google Scholar 

  13. Howard BV, Criqui MH, Curb JD, Rodabough R, Safford MM, Santoro N, Wilson AC, Wylie-Rosett J (2003) Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal White, Black, Hispanic, and Asian/Pacific Islander women. Metabolism 52:362–371

    Article  PubMed  CAS  Google Scholar 

  14. Lindsay RS, Howard BV (2004) Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep 4:3–68

    Article  Google Scholar 

  15. Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159:1104–1109

    Article  PubMed  CAS  Google Scholar 

  16. Meshkani R, Taghikhani M, Al-Kateb H, Larijani B, Khatami S, Sidiropoulos GK et al (2007) Polymorphisms within the protein tyrosine phosphatase 1B (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits. Clin Chem 53:1585–1592

    Article  PubMed  CAS  Google Scholar 

  17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197

    Google Scholar 

  18. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419

    Article  PubMed  CAS  Google Scholar 

  19. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989

    Article  PubMed  CAS  Google Scholar 

  20. Huang Q, Wang TH, Lu WS, Mu PW, Yang YF, Liang WW, Li CX, Lin GP (2006) Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou. Chin Med J (Engl) 119:1794–1801

    CAS  Google Scholar 

  21. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takács I, Lakatos P (2001) Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144:385–389

    Article  PubMed  CAS  Google Scholar 

  22. Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, Gordon CJ, Freedman BI, Rich SS, Bowden DW, Sale MM (2007) Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes 56:675–684

    Article  PubMed  CAS  Google Scholar 

  23. Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proença C, Efendic S, Ostenson CG, Brismar K, Charpentier G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR (2008) Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose. Pharmacogenet Genomics 18:967–975

    Article  PubMed  CAS  Google Scholar 

  24. Golkhu S, Ghaedi N, Mohammad Taghvaie N, Boroumand MA, Davoodi Gh, Aminzadegan A, Poorgoli L, Fathollahi MS (2009) Genetic polymorphisms of estrogen receptors in Iranian women with diabetes and coronary artery disease. Iran J Med Sci 34:208–212

    Google Scholar 

  25. Mendelsohn ME, Rosano GM (2003) Hormonal regulation of normal vascular tone in males. Circ Res 93:1142–1145

    Article  PubMed  CAS  Google Scholar 

  26. Sudhir K, Chou TM, Chatterjee K et al (1997) Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96:3774–3777

    PubMed  CAS  Google Scholar 

  27. Matsunaga T, Gu N, Yamazaki H, Adachi T, Yasuda K, Moritani T, Tsuda K, Nishiyama T, Nonaka M (2010) Association of estrogen receptor-alpha gene polymorphisms with cardiac autonomic nervous activity in healthy young Japanese males. Clin Chim Acta 411:505–509

    Article  PubMed  CAS  Google Scholar 

  28. Shearman AM, Cooper JA, Kotwinski PJ et al (2006) Estrogen receptor alpha gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res 98:590–592

    Article  PubMed  CAS  Google Scholar 

  29. Xu H, Hou X, Wang N et al (2008) Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population. Clin Chim Acta 395:130–133

    Article  PubMed  CAS  Google Scholar 

  30. Shearman AM, Cooper JA, Kotwinski PJ et al (2005) Estrogen receptor alpha gene variation and the risk of stroke. Stroke 36:2281–2282

    Article  PubMed  CAS  Google Scholar 

  31. Yoshihara R, Utsunomiya K, Gojo A, Ishizawa S, Kanazawa Y, Matoba K, Taniguchi K, Yokota T, Kurata H, Yokoyama J, Urashima M, Tajima N (2009) Association of polymorphism of estrogen receptor-alpha gene with circulating levels of adiponectin in postmenopausal women with type 2 diabetes. J Atheroscler Thromb 16:250–255

    Article  PubMed  CAS  Google Scholar 

  32. Santen RJ (1998) Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139:4164–4174

    Article  PubMed  Google Scholar 

  33. Harman SM (2006) Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med 3:254–269

    Article  PubMed  Google Scholar 

  34. Louet JF, LeMay C, Mauvais-Jarvis F (2004) Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6:180–185

    Article  PubMed  Google Scholar 

  35. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C et al (2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the women’s health initiative hormone trial. Diabetologia 47:1175–1187

    Article  PubMed  CAS  Google Scholar 

  36. Ryan AS, Nicklas BJ, Berman DM (2002) Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25:127–133

    Article  PubMed  CAS  Google Scholar 

  37. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, Khan A (2006) Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588–597

    Article  PubMed  CAS  Google Scholar 

  38. Fisher CR, Graves KH, Parlow AF, Simpson ER (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 95:6965–6970

    Article  PubMed  CAS  Google Scholar 

  39. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735–12740

    Article  PubMed  CAS  Google Scholar 

  40. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y (2003) Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176:237–246

    Article  PubMed  CAS  Google Scholar 

  41. Andò S, Panno ML, Salerno M, Sisci D, Mauro L, Lanzino M, Surmacz E (1998) Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells. Biochem Biophys Res Commun 253:315–319

    Article  PubMed  Google Scholar 

  42. Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, Soeller WC (2002) Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51:2158–2169

    Article  PubMed  CAS  Google Scholar 

  43. Sottile V, Seuwen K, Kneissel M (2004) Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif Tissue Int 75:329–337

    Article  PubMed  CAS  Google Scholar 

  44. Wang X, Abdel-Rahman AA (2002) Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol 282:H2309–H2315

    PubMed  CAS  Google Scholar 

  45. Demissie S, Cupples LA, Shearman AM, Gruenthal KM, Peter I, Schmid CH, Karas RH, Housman DE, Mendelsohn ME, Ordovas JM (2006) Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham heart study. Atherosclerosis 185:210–218

    Article  PubMed  CAS  Google Scholar 

  46. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord. 27:1020–1027

    Article  PubMed  CAS  Google Scholar 

  47. Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, Bryer-Ash M, Rich SS, Bowden DW, Sale MM (2007) Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the insulin resistance atherosclerosis family study. Diabetes 56:2135–2141

    Article  PubMed  CAS  Google Scholar 

  48. Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM, Levy D, Mendelsohn ME, Housman DE, Shearman AM (2005) Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the framingham heart study. J Clin Endocrinol Metab 90:6257–6262

    Article  PubMed  CAS  Google Scholar 

  49. Goulart AC, Zee RY, Rexrode KM (2009) Estrogen receptor 1 gene polymorphisms and decreased risk of obesity in women. Metabolism 58:759–764

    Article  PubMed  CAS  Google Scholar 

  50. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Grønholdt ML, Grande P, Jensen GB, Nordestgaard BG (2007) Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 115:861–871

    Article  PubMed  CAS  Google Scholar 

  51. Lo JC, Zhao X, Scuteri A, Brockwell S, Sowers MR (2006) The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. Am J Med 119:S69–S78

    Article  PubMed  CAS  Google Scholar 

  52. Sasaki M, Tanaka Y, Sakuragi N, Dahiya R (2003) Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations. Eur J Clin Pharmacol 59:389–393

    Article  PubMed  CAS  Google Scholar 

  53. Sowers MR, Symons JP, Jannausch ML, Chu J, Kardia SR (2006) Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women’s Health Across the Nation (SWAN). Am J Med 119:S61–S68

    Article  PubMed  CAS  Google Scholar 

  54. Saberi H, Mohammadtaghvaei N, Gulkho S, Bakhtiyari S, Mohammadi M, Hanachi P, Gerayesh-Nejad S, Zargari M, Ataei F, Parvaneh L, Larijani B, Meshkani R (2011) The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population. Mol Cell Biochem 350:113–118

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR, Iran

    Reza Meshkani & Hamzeh Saberi

  2. The Department of Laboratory Medicine, Faculty of Paramedical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR, Iran

    Narges MohammadTaghvaei

  3. The Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR, Iran

    Mohammad Amin Tabatabaiefar

Authors
  1. Reza Meshkani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamzeh Saberi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Narges MohammadTaghvaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Amin Tabatabaiefar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reza Meshkani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meshkani, R., Saberi, H., MohammadTaghvaei, N. et al. Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects. Mol Cell Biochem 359, 225–233 (2012). https://doi.org/10.1007/s11010-011-1017-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-1017-9

Keywords

Search

Navigation